These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 34372690)

  • 1. Longitudinal Measurement Invariance of the PHQ-9 and GAD-7.
    Ong CW; Pierce BG; Klein KP; Hudson CC; Beard C; Björgvinsson T
    Assessment; 2022 Dec; 29(8):1901-1916. PubMed ID: 34372690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are comparisons of mental disorders between Chinese and German students possible? An examination of measurement invariance for the PHQ-15, PHQ-9 and GAD-7.
    Zhou Y; Xu J; Rief W
    BMC Psychiatry; 2020 Oct; 20(1):480. PubMed ID: 33004042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample.
    Brattmyr M; Lindberg MS; Solem S; Hjemdal O; Havnen A
    BMC Psychiatry; 2022 Jul; 22(1):461. PubMed ID: 35818021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement invariance of the patient health questionnaire-9 (PHQ-9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005-2016.
    Patel JS; Oh Y; Rand KL; Wu W; Cyders MA; Kroenke K; Stewart JC
    Depress Anxiety; 2019 Sep; 36(9):813-823. PubMed ID: 31356710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement invariance of the PHQ-9 and GAD-7 across males and females seeking treatment for common mental health disorders.
    Saunders R; Moinian D; Stott J; Delamain H; Naqvi SA; Singh S; Wheatley J; Pilling S; Buckman JEJ
    BMC Psychiatry; 2023 Apr; 23(1):298. PubMed ID: 37118684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement invariance and differential item functioning of the PHQ-9 and GAD-7 between working age and older adults seeking treatment for common mental disorders.
    Delamain H; Buckman JEJ; Stott J; John A; Singh S; Pilling S; Saunders R
    J Affect Disord; 2024 Feb; 347():15-22. PubMed ID: 37989437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent structure and factor invariance of somatic symptoms in the patient health questionnaire (PHQ-15).
    Cano-García FJ; Muñoz-Navarro R; Sesé Abad A; Moretti LS; Medrano LA; Ruiz-Rodríguez P; González-Blanch C; Moriana JA; Cano-Vindel A
    J Affect Disord; 2020 Jan; 261():21-29. PubMed ID: 31600584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On Dimensionality, Measurement Invariance, and Suitability of Sum Scores for the PHQ-9 and the GAD-7.
    Stochl J; Fried EI; Fritz J; Croudace TJ; Russo DA; Knight C; Jones PB; Perez J
    Assessment; 2022 Apr; 29(3):355-366. PubMed ID: 33269612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement invariance of assessments of depression (PHQ-9) and anxiety (GAD-7) across sex, strata and linguistic backgrounds in a European-wide sample of patients after Traumatic Brain Injury.
    Teymoori A; Real R; Gorbunova A; Haghish EF; Andelic N; Wilson L; Asendorf T; Menon D; von Steinbüchel N
    J Affect Disord; 2020 Feb; 262():278-285. PubMed ID: 31732280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal measurement invariance of the patient health questionnaire in a German sample.
    Moehring A; Guertler D; Krause K; Bischof G; Rumpf HJ; Batra A; Wurm S; John U; Meyer C
    BMC Psychiatry; 2021 Aug; 21(1):386. PubMed ID: 34348669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in Depression and Anxiety Symptoms: Measurement Invariance, Prevalence, and Symptom Heterogeneity Among University Students in South Africa.
    Tadi NF; Pillay K; Ejoke UP; Khumalo IP
    Front Psychol; 2022; 13():873292. PubMed ID: 35712197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexuality and gender invariance of the PHQ-9 and GAD-7: Implications for 16 identity groups.
    Borgogna NC; Brenner RE; McDermott RC
    J Affect Disord; 2021 Jan; 278():122-130. PubMed ID: 32956961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic.
    Shevlin M; Butter S; McBride O; Murphy J; Gibson-Miller J; Hartman TK; Levita L; Mason L; Martinez AP; McKay R; Stocks TV; Bennett KM; Hyland P; Vallieres F; Valiente C; Vazquez C; Contreras A; Peinado V; Trucharte A; Bertamini M; Panzeri A; Bruno G; Granziol U; Mignemi G; Spoto A; Vidotto G; Bentall RP
    BMC Psychiatry; 2022 Mar; 22(1):154. PubMed ID: 35232409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factorial invariance of the Patient Health Questionnaire and Generalized Anxiety Disorder Questionnaire.
    Ryan TA; Bailey A; Fearon P; King J
    Br J Clin Psychol; 2013 Nov; 52(4):438-49. PubMed ID: 24117915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor structure and longitudinal measurement invariance of PHQ-9 for specialist mental health care patients with persistent major depressive disorder: Exploratory Structural Equation Modelling.
    Guo B; Kaylor-Hughes C; Garland A; Nixon N; Sweeney T; Simpson S; Dalgleish T; Ramana R; Yang M; Morriss R
    J Affect Disord; 2017 Sep; 219():1-8. PubMed ID: 28501679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement invariance of the GAD-5 Generalized Anxiety Disorder Scale in a Mexican general population sample.
    Astudillo-García CI; Austria-Corrales F; Rivera-Rivera L; Reynales-Shigematsu LM; Gómez-García JA; Séris-Martinez M; Jiménez-Tapia A; Robles R; Morales-Chainé S; López-Montoya A; Cuevas-Renaud C; Toledano-Toledano F
    Front Psychiatry; 2022; 13():973134. PubMed ID: 36299536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Depression-Severity in Critically Ill Patients' Families with the Patient Health Questionnaire (PHQ): Tests for Unidimensionality and Longitudinal Measurement Invariance, with Implications for CONSORT.
    Downey L; Hayduk LA; Curtis JR; Engelberg RA
    J Pain Symptom Manage; 2016 May; 51(5):938-46. PubMed ID: 26706625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factorial invariance of a computerized version of the GAD-7 across various demographic groups and over time in primary care patients.
    Moreno E; Muñoz-Navarro R; Medrano LA; González-Blanch C; Ruiz-Rodríguez P; Limonero JT; Moretti LS; Cano-Vindel A; Moriana JA
    J Affect Disord; 2019 Jun; 252():114-121. PubMed ID: 30981054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing anxiety symptom severity in Rwandese adolescents: cross-gender measurement invariance of GAD-7.
    Niwenahisemo LC; Hong S; Kuang L
    Front Psychiatry; 2024; 15():1346267. PubMed ID: 38528981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement Invariance of the GAD-7 and CESD-R-10 Among Adolescents in Canada.
    Romano I; Ferro MA; Patte KA; Leatherdale ST
    J Pediatr Psychol; 2022 May; 47(5):585-594. PubMed ID: 35552429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.